215 related articles for article (PubMed ID: 34783396)
21. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
Jing R; Yang WH; Xiao M; Li Y; Zou GL; Wang CY; Li XW; Xu YC; Hsueh PR
J Microbiol Immunol Infect; 2022 Apr; 55(2):282-290. PubMed ID: 33839057
[TBL] [Abstract][Full Text] [Related]
22. Secondary metabolite profiles and antifungal drug susceptibility of Aspergillus fumigatus and closely related species, Aspergillus lentulus, Aspergillus udagawae, and Aspergillus viridinutans.
Tamiya H; Ochiai E; Kikuchi K; Yahiro M; Toyotome T; Watanabe A; Yaguchi T; Kamei K
J Infect Chemother; 2015 May; 21(5):385-91. PubMed ID: 25737146
[TBL] [Abstract][Full Text] [Related]
23. Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
Negri CE; Gonçalves SS; Xafranski H; Bergamasco MD; Aquino VR; Castro PT; Colombo AL
J Clin Microbiol; 2014 Oct; 52(10):3633-40. PubMed ID: 25078909
[TBL] [Abstract][Full Text] [Related]
24. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Mortensen KL; Johansen HK; Fuursted K; Knudsen JD; Gahrn-Hansen B; Jensen RH; Howard SJ; Arendrup MC
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1355-63. PubMed ID: 21541671
[TBL] [Abstract][Full Text] [Related]
25.
Pinto E; Monteiro C; Maia M; Faria MA; Lopes V; Lameiras C; Pinheiro D
Front Microbiol; 2018; 9():1656. PubMed ID: 30083151
[No Abstract] [Full Text] [Related]
26. Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112
Carrara B; Richards R; Imbert S; Morio F; Sasso M; Zahr N; Normand AC; Le Pape P; Lachaud L; Ranque S; Maubon D; Piarroux R; Fekkar A
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312779
[No Abstract] [Full Text] [Related]
27. Epidemiology and Antifungal Susceptibility Profile of
Cho SY; Lee DG; Kim WB; Chun HS; Park C; Myong JP; Park YJ; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018982
[TBL] [Abstract][Full Text] [Related]
28. Species distribution and antifungal susceptibility patterns of Aspergillus isolates from clinical specimens and soil samples in Mexico.
Treviño-Rangel RJ; Villanueva-Lozano H; Bonifaz A; Castañón-Olivares LR; Andrade A; Becerril-García MA; Martínez-Reséndez MF; Ayala-Gaytán J; Montoya AM; González GM
Med Mycol; 2021 Oct; 59(10):1006-1014. PubMed ID: 34021564
[TBL] [Abstract][Full Text] [Related]
29. Rare/cryptic Aspergillus species infections and importance of antifungal susceptibility testing.
Tsang CC; Tang JYM; Ye H; Xing F; Lo SKF; Xiao C; Han L; Wu AKL; Ngan AHY; Law KC; To YN; Sze DTT; Chim OHY; Hui TWS; Leung CWH; Zhu T; Yao C; Tse BPH; Lau SKP; Woo PCY
Mycoses; 2020 Dec; 63(12):1283-1298. PubMed ID: 32918365
[TBL] [Abstract][Full Text] [Related]
30. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
[TBL] [Abstract][Full Text] [Related]
31.
Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
[TBL] [Abstract][Full Text] [Related]
32. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
[TBL] [Abstract][Full Text] [Related]
33. The emergence of azole resistance in Aspergillus fumigatus complex in New Zealand.
McKinney WP; Vesty A; Sood J; Bhally H; Morris AJ
N Z Med J; 2021 Jun; 134(1536):41-51. PubMed ID: 34140712
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species.
Misra R; Malik A; Singhal S
Indian J Pathol Microbiol; 2011; 54(1):112-6. PubMed ID: 21393890
[TBL] [Abstract][Full Text] [Related]
35. Species distribution and antifungal susceptibility of
Osman M; Bidon B; Abboud C; Zakaria A; Hamze B; Achcar ME; Mallat H; Dannaoui E; Dabboussi F; Papon N; Bouchara JP; Hamze M
Future Microbiol; 2021 Jan; 16(1):13-26. PubMed ID: 33438473
[No Abstract] [Full Text] [Related]
36. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.
Escribano P; Rodríguez-Sánchez B; Díaz-García J; Martín-Gómez MT; Ibáñez-Martínez E; Rodríguez-Mayo M; Peláez T; García-Gómez de la Pedrosa E; Tejero-García R; Marimón JM; Reigadas E; Rezusta A; Labayru-Echeverría C; Pérez-Ayala A; Ayats J; Cobo F; Pazos C; López-Soria L; Alastruey-Izquierdo A; Muñoz P; Guinea J;
Clin Microbiol Infect; 2021 Aug; 27(8):1170.e1-1170.e7. PubMed ID: 33010446
[TBL] [Abstract][Full Text] [Related]
37. [Cryptic Aspergillus species - a case report of chronic cavitary pulmonary Aspergillus lentulus infection in a heart transplant recipient].
Lysková P; Skružná M; Kubánek M; Kautznerová D; Hošková L; Vrbská J; Žáčková P; Dobiáš R; Jaworská P; Mrázek J; Sumerauerová P; Němcová D; Hubka V
Klin Mikrobiol Infekc Lek; 2019 Jun; 25(2):48-52. PubMed ID: 31971247
[TBL] [Abstract][Full Text] [Related]
38. [Causative Agents of Aspergillosis Including Cryptic Aspergillus Species and A. fumigatus].
Toyotome T
Med Mycol J; 2016; 57(4):J149-J154. PubMed ID: 27904060
[TBL] [Abstract][Full Text] [Related]
39. Molecular identification of clinical and environmental avian Aspergillus isolates.
Sabino R; Burco J; Valente J; Veríssimo C; Clemons KV; Stevens DA; Tell LA
Arch Microbiol; 2019 Mar; 201(2):253-257. PubMed ID: 30627760
[TBL] [Abstract][Full Text] [Related]
40. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
Escribano P; Peláez T; Recio S; Bouza E; Guinea J
Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
